Evidence map›Paper›PMID 34578208›Full record

ReviewPathogens (Basel, Switzerland)2021

Christine Rumpf, Jonas Lange, Bianca Schwartbeck, Barbara C Kahl

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. A c-di-AMP-controlled glutamine synthesis pathway promotes persistence ofbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Microbial and host innate immune factors affecting the persistence ofFrontiers in cellular and infection microbiology · 2026
    Review
  6. Molecular epidemiology ofFrontiers in cellular and infection microbiology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Regulation of airway fumarate by host and pathogen promotesbioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. A near-complete genome of the unculturedMicrobiology resource announcements · 2024
    Article
  17. Review
  18. Therapeutic Interventions forJournal of clinical medicine · 2024
    Review
  19. Changing profile of bacterial infection and microbiome in cystic fibrosis: when to use antibiotics in the era of CFTR-modulator therapy.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  20. Arcopilins: A New Family ofJournal of medicinal chemistry · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christine RumpfInstitute of Medical Microbiology, University Hospital Münster, 48149 Münster, Germany.
Jonas LangeInstitute of Medical Microbiology, University Hospital Münster, 48149 Münster, Germany.
Bianca SchwartbeckInstitute of Medical Microbiology, University Hospital Münster, 48149 Münster, Germany.
Barbara C KahlInstitute of Medical Microbiology, University Hospital Münster, 48149 Münster, Germany.ORCID 0000-0001-5155-3383
University Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibiotic resistancecystic fibrosispathogenesispersistent infectionpopulations dynamicsspa sequence typingStaphylococcus aureuswhole genome sequencing

Identifiers

PMID34578208
PMCPMC8466686
OpenAlexW3198996171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.